These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 7896208)

  • 21. Flow cytometric study of idarubicin and daunorubicin accumulation and the effect of verapamil in leukemic cell lines and fresh cells from patients with acute non-lymphoblastic leukemia.
    Boiron JM; Belloc F; Montastruc M; Cony-Makhoul P; Dumain P; Marit G; Mahon FX; Puntous M; Lopez F; Lacombe F
    Leuk Res; 1994 May; 18(5):313-8. PubMed ID: 8182921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of P-glycoprotein modulators on cardiac uptake, metabolism, and effects of idarubicin.
    Kang W; Weiss M
    Pharm Res; 2001 Nov; 18(11):1535-41. PubMed ID: 11758760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined use of cyclosporin A and verapamil in modulating multidrug resistance in human leukemia cell lines.
    Hu XF; Martin TJ; Bell DR; de Luise M; Zalcberg JR
    Cancer Res; 1990 May; 50(10):2953-7. PubMed ID: 2334897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative evaluation of the intracellular accumulation and DNA binding of idarubicin and daunorubicin in sensitive and multidrug-resistant human leukaemia K562 cells.
    Bogush T; Robert J
    Anticancer Res; 1996; 16(1):365-8. PubMed ID: 8615637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative activity of idarubicin and idarubicinol in combination with cyclosporin A in multidrug-resistant leukemia cells.
    Tolomeo M; Gancitano RA; Musso M; Porretto F; Perricone R; Abbadessa V; Cajozzo A
    Cancer Chemother Pharmacol; 1996; 39(1-2):157-61. PubMed ID: 8995514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Idarubicin overcomes P-glycoprotein-related multidrug resistance: comparison with doxorubicin and daunorubicin in human multiple myeloma cell lines.
    Roovers DJ; van Vliet M; Bloem AC; Lokhorst HM
    Leuk Res; 1999 Jun; 23(6):539-48. PubMed ID: 10374847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative effect of verapamil, cyclosporin A and SDZ PSC 833 on rhodamine 123 transport and cell cycle in vinblastine-resistant Chinese hamster ovary cells overexpressing P-glycoprotein.
    Pétriz J; Sánchez J; Bertrán J; García-López J
    Anticancer Drugs; 1997 Oct; 8(9):869-75. PubMed ID: 9402314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemosensitisation and drug accumulation effects of cyclosporin A, PSC-833 and verapamil in human MDR large cell lung cancer cells expressing a 190k membrane protein distinct from P-glycoprotein.
    Barrand MA; Rhodes T; Center MS; Twentyman PR
    Eur J Cancer; 1993; 29A(3):408-15. PubMed ID: 8398342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered activity of MDR-reversing agents on KB3-1 cells transfected with Gly(185)-->Val human P-glycoprotein.
    Watanabe T; Uchiyama N; Roninson IB; Cohen D; Atadja P
    Int J Oncol; 2000 Sep; 17(3):579-86. PubMed ID: 10938401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Reversal of multidrug-resistance in human leukemia cell line K562/A02 by a cyclosporin D analogue PSC 833].
    Dai H; Luo S; Yin A; Peng A
    Zhonghua Xue Ye Xue Za Zhi; 2002 Jan; 23(1):23-6. PubMed ID: 12015084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of idarubicin and daunorubicin regarding intracellular uptake, induction of apoptosis, and resistance.
    Lotfi K; Zackrisson AL; Peterson C
    Cancer Lett; 2002 Apr; 178(2):141-9. PubMed ID: 11867198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of mechanisms responsible for resistance to idarubicin and daunorubicin in multidrug resistant LoVo cell lines.
    Toffoli G; Simone F; Gigante M; Boiocchi M
    Biochem Pharmacol; 1994 Nov; 48(10):1871-81. PubMed ID: 7986198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative study on reversal efficacy of SDZ PSC 833, cyclosporin A and verapamil on multidrug resistance in vitro and in vivo.
    Watanabe T; Tsuge H; Oh-Hara T; Naito M; Tsuruo T
    Acta Oncol; 1995; 34(2):235-41. PubMed ID: 7718262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of resistance to idarubicin by the cyclosporin PSC 833 (valspodar) in multidrug-resistant cells.
    Lacayo NJ; Duran GE; Sikic BI
    J Exp Ther Oncol; 2003; 3(3):127-35. PubMed ID: 14641819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The solvents cremophor EL and Tween 80 modulate daunorubicin resistance in the multidrug resistant Ehrlich ascites tumor.
    Friche E; Jensen PB; Sehested M; Demant EJ; Nissen NN
    Cancer Commun; 1990; 2(9):297-303. PubMed ID: 1976341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of P-glycoprotein-mediated vinblastine transport across HCT-8 intestinal carcinoma monolayers by verapamil, cyclosporine A and SDZ PSC 833 in dependence on extracellular pH.
    Zacherl J; Hamilton G; Thalhammer T; Riegler M; Cosentini EP; Ellinger A; Bischof G; Schweitzer M; Teleky B; Koperna T
    Cancer Chemother Pharmacol; 1994; 34(2):125-32. PubMed ID: 7910786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of flow cytometry for multidrug resistance detection in low resistance K562 cells using daunorubicin and monoclonal antibodies.
    Van Acker KL; Van Hove LM; Boogaerts MA
    Cytometry; 1993 Oct; 14(7):736-46. PubMed ID: 7902231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of S9788, a new modulator of multidrug resistance, on the cellular accumulation and subcellular distribution of daunorubicin in P-glycoprotein-expressing MCF7 human breast adenocarcinoma cells.
    Merlin JL; Marchal S; Ramacci C; Dieterlen A; Schultz G; Lucas C; Poullain MG; Berlion M
    Cytometry; 1995 Aug; 20(4):315-23. PubMed ID: 7587719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Partial inhibition of the P-glycoprotein-mediated transport of anthracyclines in viable resistant K562 cells after irradiation in the presence of a verapamil analogue.
    Mankhetkorn S; Teodori E; Garnier-Suillerot A
    Chem Biol Interact; 1999 Jul; 121(2):125-40. PubMed ID: 10418960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo circumvention of P-glycoprotein-mediated multidrug resistance of tumor cells with SDZ PSC 833.
    Boesch D; Gavériaux C; Jachez B; Pourtier-Manzanedo A; Bollinger P; Loor F
    Cancer Res; 1991 Aug; 51(16):4226-33. PubMed ID: 1678313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.